MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$103,546K
Net Income
-$2,060K
Net Profit Margin
-1.99%
EPS
-$0.07
Unit: Thousand (K) dollars
Revenue Breakdown
Non Dermatologic
Dermatologic
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net revenues
103,546
83,679
87,010
83,043
Cost of sales (exclusive of amortization of acquired intangible assets)
23,700
20,533
18,315
18,704
Research and development
14,543
14,428
13,515
12,960
Selling, general and administrative
66,122
64,899
56,731
55,907
Amortization of acquired intangible assets
2,251
2,226
2,276
2,276
Total operating expenses, net
106,616
102,086
90,837
89,847
Operating loss
-3,070
-18,407
-3,827
-6,804
Interest income
2,356
2,545
2,896
2,833
Changes in fair value of equity securities
-
-
-
3,561
Net (losses) gains on equity securities
-630
2,022
-1,759*
-
Interest expense
193
134
24
24
Other loss
-153
-439
0*
48
Loss before income taxes
-1,690
-14,413
-2,714
-386
Income tax expense (benefit)
370
109
-382
115
Net (loss) income
-2,060
-14,522
-2,332
-501
Basic EPS
-0.07
-0.49
-0.079
-0.02
Diluted EPS
-0.07
-0.49
-0.081
-0.02
Basic Average Shares
30,399,000
29,889,000
29,348,000
29,073,000
Diluted Average Shares
30,399,000
29,889,000
28,717,000
29,073,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net (loss) income
-$2,060K
(-145.54%↓ Y/Y)
Loss before income
taxes
-$1,690K
(-1081.82%↓ Y/Y)
Income tax expense
(benefit)
$370K
(107.93%↑ Y/Y)
Interest income
$2,356K
(-19.97%↓ Y/Y)
Non Dermatologic
$54,842K
(83.47%↑ Y/Y)
Dermatologic
$48,704K
(-13.49%↓ Y/Y)
Operating loss
-$3,070K
(27.78%↑ Y/Y)
Net revenues
$103,546K
(20.14%↑ Y/Y)
Net (losses) gains
on equity...
-$630K
Interest expense
$193K
(819.05%↑ Y/Y)
Other loss
-$153K
Total operating
expenses, net
$106,616K
(17.89%↑ Y/Y)
Selling, general and
administrative
$66,122K
(13.88%↑ Y/Y)
Cost of sales
(exclusive of amortization...
$23,700K
(34.46%↑ Y/Y)
Research and development
$14,543K
(13.73%↑ Y/Y)
Amortization of acquired
intangible assets
$2,251K
(14.79%↑ Y/Y)
Buy us a coffee
CASTLE BIOSCIENCES INC (CSTL)
CASTLE BIOSCIENCES INC (CSTL)